Moxifloxacin Kabi (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacin Kabi, is a fluoroquinolone antibiotic presented as an injectable solution for intravenous use. It treats a range of serious bacterial infections in adults, including community‑acquired pneumonia and complicated intra‑abdominal infections.

GNH USA supplies Moxifloxacin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Moxifloxacin Kabi is a fluoroquinolone antibiotic used to treat bacterial infections in various organ systems. - Community‑acquired bacterial pneumonia: effective bacterial eradication leading to clinical recovery. - Complicated intra‑abdominal infections: helps resolve infection after surgical source control. - Complicated skin and skin‑structure infections: reduces bacterial load and promotes healing. - Acute bacterial sinusitis: alleviates symptoms by eliminating causative pathogens.

Moxifloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Rash: skin erythema or mild pruritus. - Elevated liver enzymes: transient increases in hepatic transaminases. - Dizziness: occasional light‑headed sensation.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT interval prolongation: risk of cardiac arrhythmias, particularly torsades de pointes. - Severe allergic reactions: anaphylaxis, angioedema, or bronchospasm. - Clostridioides difficile infection: severe colitis following disruption of gut flora. - Hepatic failure: rare but potentially life‑threatening liver injury. - Anaphylactic shock: immediate hypersensitivity requiring emergency care.

Before initiating therapy with Moxifloxacin, consider the following precautions. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic disease: use with caution; monitor liver enzymes regularly. - Concomitant QT‑prolonging drugs: avoid combined use to reduce arrhythmia risk. - History of tendon disorders: discontinue if tendon pain or inflammation occurs. - Pregnancy and lactation: use only if potential benefits outweigh risks. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Moxifloxacin can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: increased risk of toxicity. - Concurrent use of QT‑prolonging agents (e.g., macrolides, antiarrhythmics): heightened arrhythmia risk. - Antacids containing aluminum or magnesium: reduce absorption of moxifloxacin.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect; monitor INR closely. - Corticosteroids: increased risk of tendon rupture; assess patient symptoms regularly.